BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7936204)

  • 1. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat.
    Alam AM; Starr MS
    Neuroscience; 1994 Jun; 60(4):1039-47. PubMed ID: 7936204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures.
    Turski WA; Cavalheiro EA; Ikonomidou C; Bortolotto ZA; Klockgether T; Turski L
    Synapse; 1990; 5(2):113-9. PubMed ID: 2137942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors.
    Alam AM; Starr MS
    Neuroscience; 1993 Mar; 53(2):425-31. PubMed ID: 8098511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
    Wahnschaffe U; Löscher W
    Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
    Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticonvulsant action of SCH 23390 in the striatum of the rat.
    al-Tajir G; Starr MS
    Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential visualization of dopamine D2 and D3 receptors in rat brain.
    Parsons B; Stanley M; Javitch J
    Eur J Pharmacol; 1993 Apr; 234(2-3):269-72. PubMed ID: 8097723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
    al-Tajir G; Chandler CJ; Starr BS; Starr MS
    Neuropharmacology; 1990 Jul; 29(7):657-61. PubMed ID: 1974713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
    Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I; Bryer JB; Starkstein SE; Honig M; Moran TH; Robinson RG
    Brain Res; 1990 Nov; 533(2):286-91. PubMed ID: 1981170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
    Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
    Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain.
    Gehlert DR; Gackenheimer SL; Seeman P; Schaus J
    Eur J Pharmacol; 1992 Feb; 211(2):189-94. PubMed ID: 1351846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant effect of striatal dopamine D2 receptor stimulation: dependence on cortical circuits?
    al-Tajir G; Starr MS
    Neuroscience; 1991; 43(1):51-7. PubMed ID: 1681459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra.
    al-Tajir G; Starr MS
    Pharmacol Biochem Behav; 1991 May; 39(1):109-13. PubMed ID: 1924492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.